TECOS analysis adds heart failure data for sitagliptin

TECOS analysis adds heart failure data for sitagliptin tecos OF FMTS FOR TECOS TRAINEES - NOVEMBER 2018 SECTION tecos Download scientific diagram Overview of Tecos software architecture from publication: On the Potential of District-Scale Life Cycle Assessments of

tecos TECOS is a randomized, double-blind, controlled trial comparing sitagliptin and placebo when added to best usual care in patients with T2DM and cardiovascular

tecos Update on TECOS safety data Session: TECOS Stockholm 2015 Jacobsohn 18 September 2015 2510 views Sorry, the player failed to load Playable file not management About the TECOS CV Safety Trial TECOS was an event-driven trial conducted in adults with type 2 diabetes and a history of